Novo Holdings, the controlling shareholder of drug maker Novo Nordisk, said on Wednesday that its total income and investment return in 2024 nearly doubled to DKK 60 billion ($8.69 billion ...

Dividends and the share repurchase programs of the Novo Group companies (Novo Nordisk and Novonesis) totaled 23 billion Danish kroner, and Returns from the Investment Portfolio generated an income ...

It has controlling stakes in Novo Nordisk, in which it has 77% of voting shares, and Novonesis. In 2024, it invested 4.6 billion euros in life sciences targeting cancer, obesity, and ...

These questions have driven Professor Julia Vorholt's groundbreaking research work, which has now earned her the 2025 Novonesis Biotechnology Prize, awarded by the Novo Nordisk Foundation.

It has controlling stakes in Novo Nordisk, in which it has 77% of voting shares, and Novonesis (NSISb.CO), opens new tab. In 2024 Novo Holdings invested 4.6 billion euros in life sciences ...

It has controlling stakes in Novo Nordisk, in which it has 77% of voting shares, and Novonesis. In 2024, it invested €4.6 billion in life sciences targeting cancer, obesity, and ...